Reviewing Quidel (QDEL) & Dynatronics (DYNT)

Quidel (NASDAQ: QDEL) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.


This table compares Quidel and Dynatronics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quidel -2.33% -2.36% -1.25%
Dynatronics -3.42% -45.78% -5.38%

Risk and Volatility

Quidel has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of -0.16, suggesting that its share price is 116% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Quidel and Dynatronics, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quidel 0 1 5 0 2.83
Dynatronics 0 0 0 0 N/A

Quidel currently has a consensus price target of $48.50, indicating a potential upside of 20.17%. Given Quidel’s higher possible upside, equities analysts plainly believe Quidel is more favorable than Dynatronics.

Institutional and Insider Ownership

92.7% of Quidel shares are held by institutional investors. Comparatively, 18.2% of Dynatronics shares are held by institutional investors. 22.0% of Quidel shares are held by company insiders. Comparatively, 51.8% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Quidel and Dynatronics’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Quidel $191.60 million 7.16 -$13.80 million ($0.15) -269.05
Dynatronics $35.76 million 0.37 -$1.86 million ($1.11) -2.45

Dynatronics has lower revenue, but higher earnings than Quidel. Quidel is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.


Quidel beats Dynatronics on 10 of the 12 factors compared between the two stocks.

Quidel Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.

Dynatronics Company Profile

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply